Literature DB >> 11165762

Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice.

Y Tomidokoro1, K Ishiguro, Y Harigaya, E Matsubara, M Ikeda, J M Park, K Yasutake, T Kawarabayashi, K Okamoto, M Shoji.   

Abstract

To clarify how Abeta deposits induce secondary tauopathy, the presence of phosphorylated tau, glycogen synthase kinase 3alpha (GSK3alpha), GSK3beta, cyclin-dependent kinase 5 (CDK5), mitogen-activated protein kinase (MAPK) and fyn were examined in the Tg2576 brain showing substantial brain Abeta amyloidosis and behavioral abnormalities. Phosphorylated tau at Ser199, Thr231/Ser235, Ser396 and Ser413 accumulated in the dystrophic neurites of senile plaques. The major kinase for tau phosphorylation was GSK3beta. Smaller contributions of GSK3alpha, CDK5 and MAPK were suggested. Thus, brain Abeta amyloidosis has a potential role in the induction of tauopathy leading to the mental disturbances of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165762     DOI: 10.1016/s0304-3940(00)01767-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.

Authors:  Annamaria Lanzillotta; Ilenia Sarnico; Marina Benarese; Caterina Branca; Cristina Baiguera; Birgit Hutter-Paier; Manfred Windisch; Pierfranco Spano; Bruno Pietro Imbimbo; Marina Pizzi
Journal:  J Mol Neurosci       Date:  2010-12-22       Impact factor: 3.444

2.  Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits.

Authors:  Jogender Mehla; Balwantsinh C Chauhan; Neelima B Chauhan
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease.

Authors:  Sozos Ch Papasozomenos; Alikunju Shanavas
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease.

Authors:  Jing Lin; Xian Li; Fangping Yuan; Ling Lin; Christine L Cook; Ch V Rao; Zhenmin Lei
Journal:  J Neuropathol Exp Neurol       Date:  2010-03       Impact factor: 3.685

5.  Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease.

Authors:  M Cuadrado-Tejedor; I Hervias; A Ricobaraza; E Puerta; J M Pérez-Roldán; C García-Barroso; R Franco; N Aguirre; A García-Osta
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

6.  Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.

Authors:  Masaki Ikeda; Mikio Shoji; Toshitaka Kawarai; Takeshi Kawarabayashi; Etsuro Matsubara; Tetsuro Murakami; Atsushi Sasaki; Yasushi Tomidokoro; Yasushi Ikarashi; Hisashi Kuribara; Koichi Ishiguro; Masato Hasegawa; Shu-Hui Yen; M Azhar Chishti; Yasuo Harigaya; Koji Abe; Koichi Okamoto; Peter St George-Hyslop; David Westaway
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

7.  NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease.

Authors:  C A Colton; M P Vitek; D A Wink; Q Xu; V Cantillana; M L Previti; W E Van Nostrand; J B Weinberg; B Weinberg; H Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

8.  Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.

Authors:  Takashi Ishizawa; Narahiko Sahara; Koichi Ishiguro; Jay Kersh; Eileen McGowan; Jada Lewis; Michael Hutton; Dennis W Dickson; Shu-Hui Yen
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  Tyrosine phosphorylation of tau by the SRC family kinases lck and fyn.

Authors:  Timothy Me Scales; Pascal Derkinderen; Kit-Yi Leung; Helen L Byers; Malcolm A Ward; Caroline Price; Ian N Bird; Timothy Perera; Stuart Kellie; Ritchie Williamson; Brian H Anderton; C Hugh Reynolds
Journal:  Mol Neurodegener       Date:  2011-01-26       Impact factor: 14.195

10.  Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain.

Authors:  Kathleen A Ryan; Sanjay W Pimplikar
Journal:  J Cell Biol       Date:  2005-10-17       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.